Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NEK2 promotes the migration and proliferation of ESCC via stabilization of YAP1 by phosphorylation at Thr-143
Wei Su, Hao Hu, Qiurong Ding, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

EGFR targeting PhosTACs as a dual inhibitory approach reveals differential downstream signaling
Zhenyi Hu, Po‐Han Chen, Wenxue Li, et al.
Science Advances (2024) Vol. 10, Iss. 13
Open Access | Times Cited: 10
Role of NEK2 in tumorigenesis and tumor progression
Jiliang Xia, Hongyan Zhao, Jacob L Edmondson, et al.
Trends in Molecular Medicine (2024)
Open Access | Times Cited: 8
Insights into NEK2 inhibitors as antitumor agents: From mechanisms to potential therapeutics
Yizhen Jiang, Yutong Wang, Feijing Su, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117287-117287
Closed Access
The critical role of the Hippo signaling pathway in renal fibrosis
Chenchen Zhao, Hongshuang Wang, Chang Xu, et al.
Cellular Signalling (2025), pp. 111661-111661
Closed Access
Targeting NEK Kinases in Gastrointestinal Cancers: Insights into Gene Expression, Function, and Inhibitors
Lei Chen, Heng Lu, Farah Ballout, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1992-1992
Open Access
NEK2 promotes the development of ovarian endometriosis and impairs decidualization by phosphorylating FOXO1
Mengxue Wang, Fangyuan Sun, Shucai Zhang, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 3
Tubuloside B, a major constituent of Cistanche deserticola, inhibits migration of hepatocellular carcinoma by inhibiting Hippo-YAP pathway
Jie Yao, Haoqiang Wan, Jingmei Zhang, et al.
Phytomedicine (2024) Vol. 129, pp. 155552-155552
Closed Access | Times Cited: 2
Differential Expression of NEK Kinase Family Members in Esophageal Adenocarcinoma and Barrett’s Esophagus
Lei Chen, Farah Ballout, Heng Lu, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4821-4821
Open Access | Times Cited: 4
PTPN23[Thr] variant reduces susceptibility and tumorigenesis in esophageal squamous cell carcinoma through dephosphorylation of EGFR
Siyuan Niu, Jialing Ma, Yueping Li, et al.
Cancer Letters (2024) Vol. 592, pp. 216936-216936
Closed Access | Times Cited: 1
NEK2 promotes colorectal cancer progression by activating the TGF-β/Smad2 signaling pathway
Hai Qin, Manqin Yuan, Yaqin Yuan, et al.
Translational Oncology (2024) Vol. 51, pp. 102186-102186
Open Access | Times Cited: 1
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Lanyue Zhang, Yang Li, Juexiao Deng, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
NEK2 promotes the progression of osteoarthritis by stabilizing ATF2 through phosphorylation at Ser-112 and inhibiting autophagy
Zhiqin Li, Xiaofeng Li, Hongli Xia, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113833-113833
Closed Access | Times Cited: 1
Development of a Novel Prognostic Model for Esophageal Squamous Cell Carcinoma: Insights into Immune Cell Interactions and Drug Sensitivity
Pu Wang, Yu Liu, Lingyu Wei, et al.
Cancer Investigation (2024) Vol. 42, Iss. 3, pp. 243-259
Open Access
NEK2 promotes TP53 ubiquitination to enhance the proliferation and migration of TP53 wild-type glioblastoma cells
Yu Zhang, Hao Yu, Mengyao He, et al.
Neoplasma (2024) Vol. 71, Iss. 03, pp. 255-265
Open Access
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Lanyue Zhang, Yang Li, Wenxin Liao, et al.
Research Square (Research Square) (2024)
Open Access
Exploring the hub genes and mechanisms of Daphne altaica. treating esophageal squamous cell carcinoma based on Network Pharmacology and Bioinformatics Analysis
Sendaer Hailati, Ziruo Talihati, Kayisaier Abudurousuli, et al.
Research Square (Research Square) (2023)
Open Access
Exploring the hub genes and mechanisms of Daphne altaica treating esophageal squamous cell carcinoma based on network pharmacology and bioinformatics analysis
Sendaer Hailati, Ziruo Talihati, Kayisaier Abudurousuli, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 11, pp. 8467-8481
Open Access
Development of a Novel Prognostic Model for Esophageal Squamous Cell Carcinoma: Insights into Immune Cell Interactions and Drug Sensitivity
Pu Wang, Bin Du, Lingyu Wei, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top